SlideShare uma empresa Scribd logo
1 de 14
Baixar para ler offline
Corporate Capabilities Brief

                          2012-2013


 Your Success is Our Success!




          EmpiriStat, Inc., 13694 Sam Hill Drive, Mount Airy, MD 21771
 1-866-935-STAT or 240-744-0000  Fax 866-276-STAT  www.empiristat.com 
EmpiriStat, Inc.
2012-2013 Corporate Capabilities Brief




           Corporate Summary
At EmpiriStat our work lies at the intersection of science and practice, in collaboration with partners for
the design, implementation and analysis of clinical trials and research studies. With our in-depth
biostatistical and methodological experience, we navigate through the myriad of regulations and research
guidelines to ensure a successful clinical trial and clinical program, and even more importantly,
relationship with the US and European regulatory bodies that may be involved in that pathway. We
operate as members of the team, while moving our client’s product forward on its given timeline.
EmpiriStat provides research support for animal model studies, in-vivo and in-vitro diagnostic testing and
full Phase I to IV clinical support, with post marketing analysis throughout a wide range of therapeutic
areas and devices. We offer a variety of customizable services of high-end development and knowledge
in:

    Biostatistics and Statistical Programming                Risk Based Monitoring
    Regulatory planning, support & submission                Epidemiological Cohort and Longitudinal
    for INDs, BLAs, PMA, 510ks, and IDEs                     Studies
    Data and Safety Monitoring Board services                Capacity Building Training for Existing and
    (masked and unmasked statistical support),               Developing Programs
    Charter Services and Administrative Duties               Clinical Research Support Staffing for
    Clinical Data Management support                         Government and Industry


EmpiriStat’s founder Dr. Nicole C. Close wasn’t satisfied to cruise the easy road, she has continually
challenged herself and those around her. Under the guidance of mentors she was encouraged to think
beyond boundaries. This no-limits approach became a unique part of her professional methodology. In
March of 2008 with a unique goal in mind: to discover the truth as far as possible, EmpiriStat was born.
It has always been EmpiriStat’s position to provide comprehensive and cost efficient clinical development
options while delivering the highest quality product. Responsibility to each other and to our clients is
our expectation.

With established key relationships in Biotechnology, Industry, Government, and Academic clients,
                                              EmpiriStat has developed an unparalleled ability to
                                              provide comprehensive services. This, in combination
              Quick Facts                     with a powerful team of subject matter experts in
                                              scientific, regulatory, and logistical aspects of clinical
     Woman-Owned Small Business               research, EmpiriStat has the ability to understand our
     CAGE Code: 53F97                         client's goals and provide the necessary contributions
                                              required to achieve them. Driven by our passion for
     DUNS Number: 826391034
                                              science and overcoming the challenges associated with
     Small Business NAICS 518210,             research, we can confidently state that our clients’
     541519, 541611, 541690, 541712,          success is our success.
                                              We genuinely care about our collaborators. We get to
     541720, 541990, 611420, 611430
                                              know them, their families, their hobbies and we share
     FWA 00015488                             with them as well. It’s the personal attributes of our
     Navy FWA Addendum                        team that makes us easy to work with and our passion
                                              and excitement for science and research is evident in all
     Air Force FWA Addendum                   we do.


2|P age
EmpiriStat, Inc.
2012-2013 Corporate Capabilities Brief




                         Why EmpiriStat
                              Strategic U.S. Clinical Development Partner

                              Statistically and Methodologically Focused for Design,
                              Implementation and Analysis

                              Expert Therapeutic, Industry, and Regulatory Knowledge

                              Proven And Successful Track Record

                              Close Proximity To The FDA and Working Knowledge of FDA
                              Divisions and BIMO

                              Personalized "Hands-On" Customer Focus

                              Seamless, Secure Virtual Approach

                              Outstanding Communication

                              Flexible and Responsive

                              Competitive Cost Structure / Tailored Services

                              Dedicated Team for the Program/Client

                              Simply Put… We are Energetic, Love our Careers and are FUN
                              to Work With

                              Recognized by the business community:

                                  o Voted the Best Place to Work in Frederick, Maryland
                                    (Small Business) in 2011
                                  o Voted 2012 Frederick County Technology Awards, Small
                                    Business of the Year
                                  o Voted 2011 Entrepreneur of the Year for Women in
                                    Technology, Dr. Nicole C. Close, Washington, DC




3|P age
EmpiriStat, Inc.
2012-2013 Corporate Capabilities Brief




                             Biostatistical Synergy©
It takes a team approach for the successful completion of a research study or for the development of a
new device or drug product. It entails substantial integration of collaborators, both internal and external,
to research, develop, register, and ultimately market a new product. In order to achieve success one must
be able to effectively orchestrate these complex tasks.

EmpiriStat has collaborated with clients and organizations in almost every industry and specialty—both
in the U.S. and countries around the world. We have developed and refined a rigorous, effective
foundation of methodologies that are fluid yet repeatable—enabling us to quickly adapt to each new
project and provide the high level of personal service and reliability that is the core of our reputation.




            EmpiriStat's Methodologies Adapt to Every Industry and Therapeutic
More and more pharmaceutical and biotech companies are strategically outsourcing their development
needs to CRO partners that have exceptional skills in defined areas. As a result, the role of the CRO as a
service provider is rapidly changing. Companies are now moving toward a strategic outsourcing model
to maximize clinical development efficiencies and product quality. And as industry diversifies, EmpiriStat
is able to adapt and promote our strong capabilities within specific areas and stages of drug development,
rather than simply providing time and material support as the traditional CRO does. We have
successfully and seamlessly integrated into our collaborators development programs, not only by
providing operational support and services, but by providing strategic insight into the unique clinical
development challenges.

EmpiriStat, Inc. is ideally positioned to provide the most value to our collaborators. Most
importantly, we have positioned ourselves with the latest technology and methodology to harness
cost effective strategies for start-up and small to mid-size partners. We offer an impressive solution
tailored to each client to maximize quality, efficiency, and support, without sacrificing responsiveness or
flexibility. Whether it's for a clinical trial, important post-marketing efforts, outcome registry, or
augmenting your staff, we bring a strong scientific and integrated approach that positions your research
strategy appropriately. By utilizing our collective knowledge and experience, we ensure our collaborators
achieve great success.

4|P age
EmpiriStat, Inc.
2012-2013 Corporate Capabilities Brief




                    Our Collaborators
EmpiriStat has collaborated with more than 30 clients in support of over 100 clinical trials since our
beginning in 2008. Our experience encompasses a full range of clinical trial management services from
early protocol development through post market surveillance. Our team has supported every stage of
drug and device development from bench to bedside. We are always looking to expand our knowledge
and apply our skill set to new areas as well.




                                         Snapshot of our Industry, Government
                                               and Academic Partners




5|P age
EmpiriStat, Inc.
2012-2013 Corporate Capabilities Brief




                                Our Experience
Government
EmpiriStat works closely with government entities such as the United States Department of Defense
(DoD), the National Institutes of Health, and the United States Food and Drug Administration for such
tasks including:
       Clinical Data Management
       Biostatistics and Statistical Programming
       Safety Monitoring and Reporting
       Project Management
       Regulatory Processes and Management of Investigational New Drug Applications (INDs)
       Safety Monitoring and GCP Training
       Providing Subject Matter Expertise in the development of Risk Based Monitoring Tools

Non-Profit Organizations
EmpiriStat works with non-profit organizations like the United Network for Organ Sharing (UNOS), The
Henry M. Jackson Foundation for the Advancement of Military Medicine and the United States
President's Emergency Plan for AIDS Relief (PEPFAR) performing such tasks as:
       Design of domestic and international epidemiological studies
       Health Survey and Questionnaire Design and implementation strategies
       Process and management approach for effective data collection and statistical practices
       Final statistical analyses for study reports and manuscripts
       Scientific mentoring of scientists and validation procedures
       Clinical Trial Training of clinicians, nurses and research staff in East and West Africa

Private Industry
EmpiriStat provides a wide range of services to private companies like Alexza Pharmaceuticals, Soluble
Systems, and Research & Diagnostic Antibodies including:
       Consulting for integration of statistical analyses in FDA New Drug Applications (NDAs)
       Grant writing and funding support
       510(k) and PMA support
       In-vitro device trial support
       Validation of final statistical results for an Integrated Summary of Safety (ISS) and Integrated
        Summary of Efficacy (ISE)
       Providing management strategy and design methodology for clinical and health research
       Design, management, and clinical monitoring of clinical studies

Academia and Private Practice
EmpiriStat collaborates with academic institutions like the Schulze Diabetes Institute at the University of
Minnesota and Coastal Carolinas Integrated Medicine on tasks including
       Regulatory strategy for studies leading to a Biologics License Application (BLA) with the FDA
       Clinical data management, project management, biostatistics and clinical monitoring
       Clinical trial support and statistical analysis for IND studies
       Grant writing support and strategy

6|P age
EmpiriStat, Inc.
2012-2013 Corporate Capabilities Brief




         Summary of Services
EmpiriStat is committed to providing the highest quality services, superior performance, and unmatched
customer accommodation. Every team member at EmpiriStat possesses a comprehensive knowledge of
regulatory affairs and applicable FDA and ICH guidances-- from our statistical and programming group,
to clinical data management to our clinical monitors.

It is our internal strengths, corporate structure and standard operating procedures, and most importantly
synergy as a team, that eliminates errors and redundancies that are not tolerable. Below we provide a
brief overview of our expertise, but highly recommend calling us to speak with us personally.

Biostatistics and Statistical Programming
Our biostatistician’s provide statistical guidance on all clinical development program strategies,
development of optimal study designs, endpoint selection, sample size, randomization, blinding, and the
appropriate statistical methods for each design. They provide guidance on the selection of optimal
efficacy and safety endpoints and are particularly versed in various statistical methods, including what
may or may not be accepted for products and devices with the FDA. They know the importance of
planning for the collection of data, in terms of the study design and testing of the hypothesis(es). Sample
size and power calculations are devised based on previous literature, FDA expectations and guidelines,
and the appropriate statistical methodology chosen. We understand and are ready to recommend the
appropriate statistical techniques, even when those techniques may not be the “standard” for the field
currently or devise a mathematical approach to address that specific situation. We can cite the traditional
tests that we have experience in but our knowledge and the application of that knowledge is where we
excel.

We have served as presenting statisticians at the DSMB on behalf of the study and Sponsor, as well as the
DSMB statistician, and as the unblinded reporting statistician. We prepare all appropriate statistical
programming and reports based on our function, have a full understanding of the data, and can provide
quick analyses and reporting during the meeting if the Chair requires it. Any statistician that works in any
role of the DSMB is thoroughly versed in sequential monitoring techniques, understands the role of the
DSMB, is able to explain the statistical methodology of those sequential techniques, futility analyses,
statistical penalties for multiple looks at the data, and statistical justification for stopping early for
efficacy or safety.

In addition, we provide full CDISC implementation for your submissions through SDTM conversion and
ADaM datasets. We have internally implemented documented techniques that saves our collaborators
time during SDTM conversion, and have tips at the beginning of the studies on how some of our methods
can be adapted early in the process. It is never too early to have your ISS and ISE analyses and plans
developed to be implemented through your various phases as well.

It is our excellence in communication of statistical methodology, reasoning and presentation of analyses,
that has captured the interest of our clients. Our explanation to an investigator, interdisciplinary team,
Data and Safety Monitoring Board, or a lay person is made in a way for that concept to be understood.
We all consider ourselves at EmpiriStat constant learners, educators and mentors. If we cannot explain to
you why we should do something the way we propose, or give you options and the reasoning behind
those options, and you do not understand—that is our fault. It is our duty to teach, recommend and
learn.



7|P age
EmpiriStat, Inc.
2012-2013 Corporate Capabilities Brief

Training
An effective training plan is an essential requirement at the start of a study to deliver consistency
                                                            throughout the study by ensuring a uniform
                                                                interpretation of the study protocol, CRFs,
                                                                 safety, and all study procedures. Our
                                                                 training agenda’s include study-specific
                                                                 training (protocol review and execution,
                                                                CRF training, safety) as well as general
                                                                clinical training (ICH/GCP, investigative
                                                                site expectations, and other key topics).
                                                                With EmpiriStat you get a team that is well
                                                                versed and experienced in preparing and
                                                                delivering training for clinical researchers.
                                                                We also provide Capacity Building for
                                                                research centers within and outside the
                                                                United States. The EmpiriStat Series 101
                                                                Training is comprised of a four day hands-
                                                             on course that provides participants the
background and essentials of Epidemiology, Clinical Data Management, Clinical Trial Foundations, and
Statistics for Non-Statisticians. Participants are able to receive a valuable education and the tools
necessary to design a clinical trial, generate data reports and provide scientific critique of research. The
course also teaches attendees how to develop work-plans and standard operating procedures to ensure the
safety of study subjects during a clinical trial.

Building from that solid knowledge base, we offer a Series 201 standard course as well. In this course,
the building blocks of Series 101 are emphasized, but
are expanded upon in Epidemiological
Investigations and Analyses, Advanced Topics in
Clinical Trials, Data Management Strategies and
Implications     and    Statistical     Analyses    and
Interpretation. Training methods are very important,
and as such we used didactic, hands on and small
group sessions using skills in these areas. Our
approach is through the use of slides and presentations,
group case studies, group discussion and exploration,
directed question and answer periods and summary
quizzes for the main topics of the day.

Our success in providing this training is evident in that
we have been a leading training provider to the President’s We go anywhere in the world for you!
Emergency Program for Aids Research (PEPFAR) and
have delivered countless training sessions in clinical research throughout Africa.

There are a number of clinical trial models that may be utilized within an organization and its
departments, between an organization and its subcontractors, and within a Clinical Research Network.
Regardless of the model employed, for clinical trials to be successful, there must be collaboration
amongst the stakeholders. There should be an examination of each group’s functional roles, an
understanding of the technical methods utilized as well as an appreciation of the behaviors, relationships
and values that enable an organization to carry out complex tasks.



8|P age
EmpiriStat, Inc.
2012-2013 Corporate Capabilities Brief

Our Training Style
We understand that in the real world, personnel usually learn by seeing a problem, raising a question then
finding the answer. Our courses are structured in such a way that the material is taught in a purposeful,
sequential way, modeling after real world problem solving. Trainees will gain by the end of the course a
solid improvement/understanding, as a result of the learning activities, through the use of:

            the use of slides and presentations
            small group case study sessions on the topic area
            individual work on a problem for resolution
            group discussions and exploration
            directed question and answer periods
            summary quizzes of the main topics for the day

We also offer tailored training for our clients whether you want an on-site brown-bag training session or
an off-site training event at a designated site. Our training series and educational training modules
include Biostatistics, Data Management and Standards, Pharmacovigilence and Safety Reporting, Clinical
Monitoring and Data and Safety Monitoring Board Training.

Clinical Research Support Staffing
At EmpiriStat our staffing division focuses on providing clinical research professionals and expertise for
all therapeutic areas for products and devices. We serve the clinical research needs of our clients with
whom we partner. Our approach allows us to provide a wide range of tactical and experienced
professionals with strategic solutions to the primary challenges that our clients face.

Our approach is to listen, consult and partner with our clients.




We understand the criticality of selecting the right candidate for the right job, so we select each one
carefully. The first step in our recruiting process is identification of the appropriate skills sets, educational
and training background, and experience level required to perform each job. For each new requirement,
we consider the job duties and requirements, educational and training background needed, experience
level required, and any special skills necessary. Only through understanding our clients’ needs and careful
screening of candidates can we select the right person for each job. We consider factors such as the
desired salary range, the difficulty of finding the skills set, and the skills that are required versus the skills
that are helpful to have. Our staff carefully screens candidates’ qualifications as they relate to each client
through intense question and inquiry. This careful selection process leads to an increased level of client
satisfaction and project success.
9|P age
EmpiriStat, Inc.
2012-2013 Corporate Capabilities Brief


Risk Based Monitoring Tools
Risk based prioritization monitoring has changed the way we look at study management, monitoring and
statistical reporting. The first of two new draft guidance for industry, "Oversight of Clinical
Investigations— Risk-Based Approach to Monitoring" was released in August 2011. In conjunction with
this new guidance, the FDA will be describing a new review mechanism for monitoring Sponsors and
Clinical Research Organizations (CROs) during the IND application phase.

At EmpiriStat we understand and know how to implement the FDA guidances and at the same time
develop the steps to save a Sponsor time and resources during their clinical development program. A risk
based monitoring program provides the necessary risk assessment for clinical conduct and data collection
that applies available monitoring resources according to the identified risks – and reassesses those risks
on a regular basis throughout the study. Monitoring resources include Statistical Prioritization Reporting
as well as Regulatory Monitoring.

Sponsor Preventative Maintenance Program (SPMP)
Our Sponsor Preventative and Maintenance Program (SPMP), is a program in which we develop and
implement standard site metrics at the beginning of the IND phase for your clinical development program,
in preparation for NDA filing. We create Sponsor and site level Statistical Monitoring Reports with their
subsequent risk rankings to identify any clinical and logistical issues that will trigger possible GCP
question or concern, thus resulting in a higher probability of FDA inspection during your NDA
process. When applicable, our team works with the Sponsor to go out to the site to remedy and train on
identified issues.

EmpiriStat’s SPMP is an ongoing process; the metrics built will remain and will be automatically initiated
for all new studies and reports created for the Sponsor on a weekly, biweekly or monthly basis for
review. All reports are posted electronically to a Sponsor on a dedicated and secured file sharing system,
which the Sponsor controls on who receives access. Site Reports may also be sent and reviewed by our
team with your sites. We give comments and updates as needed on all reports.




10 | P a g e
EmpiriStat, Inc.
2012-2013 Corporate Capabilities Brief




                                         Case Studies
Challenge: A pharmaceutical company was only months away from filing their NA with the FDA.
They did not have an in-house Biostatistics/Statistical Programming group for review and writing of the
ISS SAP and to conduct validation programming for their program.

Solution: EmpiriStat collaborated with the company and provided all of the services required as the
Sponsor’s in-house Biostatistics and Statistical Programming group to support both the ISS and the NDA
filing within a very condensed timeframe without compromising quality.

Result: The Company received biostatistical guidance, writing, reviewing and statistical validation
programming from EmpiriStat to complete the filing within the existing company timelines. The
company saved time and money by consulting with EmpiriStat who provided flexible, time efficient and
cost effective services in an expedited manner set by the client’s needs.
Challenge: The client had contracted with EmpiriStat for part-time Senior Clinical and Regulatory
Affairs Management and expertise. The client was also in the process of contracting for a full service
CRO to provide Data Management, Clinical Monitoring, Safety Reporting, Biostatistics, and Regulatory
support for their multi-center clinical trial. However, the client was having contracting difficulties and
the trial timelines were being delayed.

Solution: EmpiriStat was contracted by client to expand their current services to provide a Bridge until
the CRO could be selected and contracted. In a condensed timeline of just 4 months, EmpiriStat created
the deliverables and provided the on-site professionals to initiate the clinical trial (including complete
Case Report Forms, Manual of Procedures, a Safety Reporting System, Study Specific Procedures for a
Data and Safety Monitoring Board, all training modules, Clinical Monitoring Plan and 2 certified research
coordinators and one professional consultant). A clear transition plan was developed between
EmpiriStat’s bridge of services to the CRO.

Result: The client moved forward with the deliverables required to initiate the trial without further delay,
had no cost or delay associated with a new group getting up to speed on the trial since EmpiriStat was
currently providing management guidance, and saved time and money when the CRO was hired since all
primary deliverables had been created for the study.
Challenge: A European device company was preparing for filing with the U.S. FDA with a device
already approved in Europe. They had consulted with an academic Biostatistician in the U.S., but were
unsure of the analyses and recommendations that the Biostatistician had made and was looking for an
independent opinion.

Solution: EmpiriStat was consulted to review the statistical analyses and recommendations and to
provide their own assessment prior to the company filing. EmpiriStat Principal Biostatistician, Dr. Nicole
C. Close, who has extensive U.S. Regulatory experience, along with an EmpiriStat Statistician located in
the United Kingdom who is well versed in EMEA guidance, reviewed the information and provided a
detailed Statistical Risk Analysis for the filing.

Result: The device company was provided with a detailed Statistical Risk Analysis summary and an
independent assessment. The company made modifications to their filing based on EmpiriStat’s
recommendations and successfully filed with the U.S. FDA.


11 | P a g e
EmpiriStat, Inc.
2012-2013 Corporate Capabilities Brief




                        Our Commitment
We at EmpiriStat are committed to building long lasting collaborative relationships with our clients. We
believe that to forge these effective relationships, we must remain true to our key values: responsibility,
integrity, value, and commitment to excellence in every task we undertake.
We bring the required knowledge and experience to your research and development, along with accurate
documentation, rigorous quality control, and regulatory compliance. We will work efficiently under your
tight project deadlines without compromising quality. Our goal is to ensure the highest statistical validity
through every project phase… as well as the ability to effectively communicate the results to a variety of
audiences.
EmpiriStat’s highly qualified staff includes Biostatisticians, Programmers, Regulatory Specialists, Project
Managers, Clinical Research Coordinators and Administrators, Quality Assurance Document Specialists,
and Data Managers, all led by our founder, Dr. Nicole Close, who is an experienced and trained
Biostatistician and Clinical Trialist.
Dr. Close is trained in Epidemiology and Biostatistics and has more than 16 years of professional
experience conduction and managing clinical trials and epidemiological research, including the
management of coordinating centers, and large-scale, multi-site data collection and statistical analysis
activities. Her passion for her field is expressed in the diligence and insightfulness she brings to each
project and therapeutic area. Dr. Close’s diverse background provides a solid foundation for EmpiriStat’s
corporate knowledge, supplemented by a team of highly trained colleagues in complementing areas of
expertise.
Our staff continuously seeks opportunities to interact with and educate professionals from many
disciplines, both in biostatistics and in methodological improvements that improve the outcomes and
enhance the knowledge gained from research.

                      VALUE                                                BENEFITS
Experienced team successful in providing and           Understanding of needs and requirements ensures
managing clinical research support                     that deliverables are managed on time, and within
                                                       budget
Flexibility                                            EmpiriStat fits our resources to our collaborator’s
                                                       needs. This flexibility allows us to provide
                                                       solutions for any clinical research project

Understanding Clinical Trials                          In-depth understanding of the challenges faced
                                                       when managing and supporting clinical trials




12 | P a g e
EmpiriStat, Inc.
          2012-2013 Corporate Capabilities Brief



                                                          Testimonials
I would do anything for EmpiriStat. You can trust them to do what            We asked Dr. Close to jump into a very specific role on a team already
they say they will do, which isn’t always true about contractors. They       moving at high speed toward an NDA. She did this quickly, ably and
have a sense of urgency and their work is top-notch. The fact they are       cheerfully, and her work was integral to the submission. Her attention to
a virtual company never entered my mind because they always                  detail and process were particularly appreciated, and her collaborative
deliver—and in this economy, that is what it most important.                 manner perfectly set the stage for a productive alliance.

Roger House, President                                                       Robert S. Fishman, MD, FCCP
Axiom Corporation                                                            VP, Clinical Development
                                                                             Alexza Pharmaceuticals, Inc.
EmpiriStat runs a client-focused business with customer satisfaction         The EmpiriStat team proved to be my closest collaborators on my research
and quality of services as their top priorities. They serve as the           grant proposal. They brought a precise knowledge of the grant review
protocol statisticians for my research studies, participate in data safety   process, study design, and power analysis. They were extremely helpful in
monitoring boards, and even developed a statistical capacity-building        refining the study design to improve the statistical analysis. EmpiriStat
workshop for the new researchers in Africa with whom I work. They            brought a genuine excitement about the science of our research and were
have a totally positive attitude—and are efficient, effective,               very easy to reach. They asked insightful questions and were very prompt
responsive, and flexible.                                                    in their analysis and responses. It was a great pleasure to work with such
                                                                             professionals."
Dr. Judi Chamberlin
U.S. Military HIV Research Program                                           Theodore Henderson, MD, PhD
Kisumu, Kenya                                                                The Synaptic Space
I’d heard EmpiriStat would be a good company to handle our                   You have a great programming team that is highly efficient and
statistical analysis. They were very patient while we waited for             communicates with ease. They do not sweat when the heat is on. They
regulatory clearance, then incredibly fast and efficient when clearance      were able to run with little direction and produce high quality outputs; a
finally came. Their data cleaning was nothing short of amazing, and          nice group of “thinkers” not just “doers”. I am looking forward to
when I asked them on short notice to write some abstracts for                reviewing the datasets next week or this weekend. Our sponsor will be
conferences, I was blown away by how quickly this was done—and               excited/pleased to have the tight timeline delivered ahead of schedule.
they were extremely well-written. I can’t say anything bad about             Great work!”
EmpiriStat.
                                                                             Raven Quinn, MS
Mark Breda                                                                   Biostatistician
Makerere University School of Medicine                                       Sarah Cannon Research Institute
Kampala, Uganda

You’re on the A list, but we haven’t finalized the clinical studies          One of the great characteristics Dr. Close brought to our projects was her
budget for 2010. You may safely assume we’ll call you when we                great investment in ensuring the integrity of our data. Her respect for both
ramp up. Your supervision and back-up on the mechanics of our                our data and our study goals was a primary factor in our success. Dr. Close
programming and data management was incredibly helpful in ’09.               was remarkably thorough in the processes she brought to managing data as
                                                                             well as in the analytic programming she created for us.
Robert S. Fishman, MD, FCCP
VP, Clinical Development                                                     Dr. Bob O’Brien
Alexza Pharmaceuticals, Inc.                                                 The CDM Group, Inc.

The auditors were really nice and easy to work with and made the             Good job on getting all of the reports turned around so quickly. I am sure
process very painless!                                                       UAB is very, very happy.

Sandra M. Berney, RN, ASN, CCTC                                              Amy Putnam
St. Vincent Indianapolis Hospital                                            Survey Services Manager
                                                                             UNOS Department of Evaluation and Quality

Thank you so much for all of EmpiriStat’s knowledge and effort. I            I wanted to thank you again for the great support of Cerescan…they were
consider myself lucky to be working with you!                                VERY impressed (and so was I!...)

Mike Webber                                                                  M. Veatch
Soluble Systems                                                              Quintiles



          13 | P a g e
EmpiriStat, Inc.
2012-2013 Corporate Capabilities Brief



                                                  Contact Us
Nicole C. Close, PhD
President and Principal Biostatistician
13694 Sam Hill Drive
Mount Airy, Maryland USA 21771
(TF) 866-935-7828 (x 703)
(T) 240-744-0000 (x703)
(F) 866-276-7828
nclose@empiristat.com


Caylee A. Ortega
Chief Operating Officer/Director of Business Development
13694 Sam Hill Drive
Mount Airy, Maryland USA 21771
(TF) 866-935-7828 (x 702)
(T) 240-744-0000 (x702)
(F) 866-276-7828
cortega@empiristat.com




14 | P a g e

Mais conteúdo relacionado

Mais procurados

Kelly Services - "We Do That"
Kelly Services - "We Do That"Kelly Services - "We Do That"
Kelly Services - "We Do That"tuckerpeterson
 
BioClinica and CRO Partners for Express EDCplus
BioClinica and CRO Partners for Express EDCplusBioClinica and CRO Partners for Express EDCplus
BioClinica and CRO Partners for Express EDCplusBioclinica
 
The Big Picture: Does One Size Fit All?
The Big Picture: Does One Size Fit All?The Big Picture: Does One Size Fit All?
The Big Picture: Does One Size Fit All?The Avoca Group
 
Kelly Services We Do That
Kelly Services   We Do ThatKelly Services   We Do That
Kelly Services We Do Thatguestab957f
 
Kelly Services Inc.
Kelly Services Inc.Kelly Services Inc.
Kelly Services Inc.watkiaw
 
Kelly Services, Inc. - We Do That!
Kelly Services, Inc. - We Do That!Kelly Services, Inc. - We Do That!
Kelly Services, Inc. - We Do That!jgourwit
 
BHS Considerations for Improving Charge Capture Processes_Chloe Phillips
BHS Considerations for Improving Charge Capture Processes_Chloe PhillipsBHS Considerations for Improving Charge Capture Processes_Chloe Phillips
BHS Considerations for Improving Charge Capture Processes_Chloe PhillipsChloe Phillips, MHA, RHIA
 
Start Up Strategy
Start Up StrategyStart Up Strategy
Start Up Strategylisamax
 
Evolving Your FSP Relationships to Achieve Maximum Return.pptx
Evolving Your FSP Relationships to Achieve Maximum Return.pptxEvolving Your FSP Relationships to Achieve Maximum Return.pptx
Evolving Your FSP Relationships to Achieve Maximum Return.pptxMMS Holdings
 
Arrelic services-2017
Arrelic services-2017Arrelic services-2017
Arrelic services-2017Arrelic
 
SAFE: Safety Management Software - One Platform to Manage all EHS Process
SAFE: Safety Management Software - One Platform to Manage all EHS ProcessSAFE: Safety Management Software - One Platform to Manage all EHS Process
SAFE: Safety Management Software - One Platform to Manage all EHS ProcessASK EHS Engineering & Consultants
 

Mais procurados (18)

About us
About usAbout us
About us
 
Kelly Services - "We Do That"
Kelly Services - "We Do That"Kelly Services - "We Do That"
Kelly Services - "We Do That"
 
BioClinica and CRO Partners for Express EDCplus
BioClinica and CRO Partners for Express EDCplusBioClinica and CRO Partners for Express EDCplus
BioClinica and CRO Partners for Express EDCplus
 
The Big Picture: Does One Size Fit All?
The Big Picture: Does One Size Fit All?The Big Picture: Does One Size Fit All?
The Big Picture: Does One Size Fit All?
 
Kelly Services We Do That
Kelly Services   We Do ThatKelly Services   We Do That
Kelly Services We Do That
 
Nalaka_Gamage
Nalaka_GamageNalaka_Gamage
Nalaka_Gamage
 
Kelly Services Inc.
Kelly Services Inc.Kelly Services Inc.
Kelly Services Inc.
 
Stanford Case Study October 2011
Stanford Case Study October 2011Stanford Case Study October 2011
Stanford Case Study October 2011
 
PRECYSE_Baptist_CaseStudy
PRECYSE_Baptist_CaseStudyPRECYSE_Baptist_CaseStudy
PRECYSE_Baptist_CaseStudy
 
Kelly Services
Kelly ServicesKelly Services
Kelly Services
 
AHIMA Journal_Foot in the Door_JAN15
AHIMA Journal_Foot in the Door_JAN15AHIMA Journal_Foot in the Door_JAN15
AHIMA Journal_Foot in the Door_JAN15
 
Kelly Services, Inc. - We Do That!
Kelly Services, Inc. - We Do That!Kelly Services, Inc. - We Do That!
Kelly Services, Inc. - We Do That!
 
BHS Considerations for Improving Charge Capture Processes_Chloe Phillips
BHS Considerations for Improving Charge Capture Processes_Chloe PhillipsBHS Considerations for Improving Charge Capture Processes_Chloe Phillips
BHS Considerations for Improving Charge Capture Processes_Chloe Phillips
 
Start Up Strategy
Start Up StrategyStart Up Strategy
Start Up Strategy
 
Evolving Your FSP Relationships to Achieve Maximum Return.pptx
Evolving Your FSP Relationships to Achieve Maximum Return.pptxEvolving Your FSP Relationships to Achieve Maximum Return.pptx
Evolving Your FSP Relationships to Achieve Maximum Return.pptx
 
Succor's "MyAppDev" Brochure
Succor's "MyAppDev" BrochureSuccor's "MyAppDev" Brochure
Succor's "MyAppDev" Brochure
 
Arrelic services-2017
Arrelic services-2017Arrelic services-2017
Arrelic services-2017
 
SAFE: Safety Management Software - One Platform to Manage all EHS Process
SAFE: Safety Management Software - One Platform to Manage all EHS ProcessSAFE: Safety Management Software - One Platform to Manage all EHS Process
SAFE: Safety Management Software - One Platform to Manage all EHS Process
 

Destaque

The case for social business small
The case for social business   smallThe case for social business   small
The case for social business smallPurple Spinnaker
 
Shortlist 2012
Shortlist 2012Shortlist 2012
Shortlist 2012lnash
 
3. introduction to course technologies
3. introduction to course technologies3. introduction to course technologies
3. introduction to course technologiesIECP
 
Evaluation for the factual layout
Evaluation for the factual layout Evaluation for the factual layout
Evaluation for the factual layout RubySheepie
 
Creating and Sharing Information Literacy Learning Designs
Creating and Sharing Information Literacy Learning DesignsCreating and Sharing Information Literacy Learning Designs
Creating and Sharing Information Literacy Learning DesignsEleni Zazani
 
USU Be Well Barriers and Incentives to Participation 2014
USU Be Well Barriers and Incentives to Participation 2014USU Be Well Barriers and Incentives to Participation 2014
USU Be Well Barriers and Incentives to Participation 2014Nancy Godfrey
 
Spain's first unmanned aircraft to take to the skies by the end of the year
Spain's first unmanned aircraft to take to the skies by the end of the yearSpain's first unmanned aircraft to take to the skies by the end of the year
Spain's first unmanned aircraft to take to the skies by the end of the yearvosprl15
 
Ecohealth Furniture2009
Ecohealth Furniture2009Ecohealth Furniture2009
Ecohealth Furniture2009mroberts251
 
Expectations Of The Screenager Generation
Expectations Of The Screenager GenerationExpectations Of The Screenager Generation
Expectations Of The Screenager GenerationGraham Steel
 
ACR BER Correlation to ATE for a COFDM VHF RX
ACR BER Correlation to ATE for a COFDM VHF RXACR BER Correlation to ATE for a COFDM VHF RX
ACR BER Correlation to ATE for a COFDM VHF RXPete Sarson, PH.D
 
3 August Daily market report
3 August Daily market report 3 August Daily market report
3 August Daily market report QNB Group
 
ECR Europe Forum '08. Window on the world of retail
ECR Europe Forum '08. Window on the world of retailECR Europe Forum '08. Window on the world of retail
ECR Europe Forum '08. Window on the world of retailECR Community
 
Ban krut presentation
Ban krut presentationBan krut presentation
Ban krut presentationpurithem
 
Carbon credit - นวัตกรรมทางการเงินเพื่อโลกสะอาด 2552
Carbon credit  - นวัตกรรมทางการเงินเพื่อโลกสะอาด 2552Carbon credit  - นวัตกรรมทางการเงินเพื่อโลกสะอาด 2552
Carbon credit - นวัตกรรมทางการเงินเพื่อโลกสะอาด 2552Sarod Paichayonrittha
 
Expressions d’émotion intro. notes
Expressions d’émotion intro. notesExpressions d’émotion intro. notes
Expressions d’émotion intro. notesmmarsh1
 
Hungary.ppt réka
Hungary.ppt rékaHungary.ppt réka
Hungary.ppt rékaAdygimibp
 

Destaque (17)

The case for social business small
The case for social business   smallThe case for social business   small
The case for social business small
 
Shortlist 2012
Shortlist 2012Shortlist 2012
Shortlist 2012
 
3. introduction to course technologies
3. introduction to course technologies3. introduction to course technologies
3. introduction to course technologies
 
Cwmg
CwmgCwmg
Cwmg
 
Evaluation for the factual layout
Evaluation for the factual layout Evaluation for the factual layout
Evaluation for the factual layout
 
Creating and Sharing Information Literacy Learning Designs
Creating and Sharing Information Literacy Learning DesignsCreating and Sharing Information Literacy Learning Designs
Creating and Sharing Information Literacy Learning Designs
 
USU Be Well Barriers and Incentives to Participation 2014
USU Be Well Barriers and Incentives to Participation 2014USU Be Well Barriers and Incentives to Participation 2014
USU Be Well Barriers and Incentives to Participation 2014
 
Spain's first unmanned aircraft to take to the skies by the end of the year
Spain's first unmanned aircraft to take to the skies by the end of the yearSpain's first unmanned aircraft to take to the skies by the end of the year
Spain's first unmanned aircraft to take to the skies by the end of the year
 
Ecohealth Furniture2009
Ecohealth Furniture2009Ecohealth Furniture2009
Ecohealth Furniture2009
 
Expectations Of The Screenager Generation
Expectations Of The Screenager GenerationExpectations Of The Screenager Generation
Expectations Of The Screenager Generation
 
ACR BER Correlation to ATE for a COFDM VHF RX
ACR BER Correlation to ATE for a COFDM VHF RXACR BER Correlation to ATE for a COFDM VHF RX
ACR BER Correlation to ATE for a COFDM VHF RX
 
3 August Daily market report
3 August Daily market report 3 August Daily market report
3 August Daily market report
 
ECR Europe Forum '08. Window on the world of retail
ECR Europe Forum '08. Window on the world of retailECR Europe Forum '08. Window on the world of retail
ECR Europe Forum '08. Window on the world of retail
 
Ban krut presentation
Ban krut presentationBan krut presentation
Ban krut presentation
 
Carbon credit - นวัตกรรมทางการเงินเพื่อโลกสะอาด 2552
Carbon credit  - นวัตกรรมทางการเงินเพื่อโลกสะอาด 2552Carbon credit  - นวัตกรรมทางการเงินเพื่อโลกสะอาด 2552
Carbon credit - นวัตกรรมทางการเงินเพื่อโลกสะอาด 2552
 
Expressions d’émotion intro. notes
Expressions d’émotion intro. notesExpressions d’émotion intro. notes
Expressions d’émotion intro. notes
 
Hungary.ppt réka
Hungary.ppt rékaHungary.ppt réka
Hungary.ppt réka
 

Semelhante a 2012 2013 Corporate Capabilities

2010 Empiri Stat Corporate Capabilities
2010 Empiri Stat Corporate Capabilities2010 Empiri Stat Corporate Capabilities
2010 Empiri Stat Corporate Capabilitieschkwagner
 
2011 EmpiriStat Corporate Capabilities
2011 EmpiriStat Corporate Capabilities2011 EmpiriStat Corporate Capabilities
2011 EmpiriStat Corporate Capabilitiesdhunt81
 
Creativ-Ceutical Corporate Brochure
Creativ-Ceutical  Corporate BrochureCreativ-Ceutical  Corporate Brochure
Creativ-Ceutical Corporate Brochuremskarray
 
Readying Your Science for the Real World
Readying Your Science for the Real WorldReadying Your Science for the Real World
Readying Your Science for the Real WorldNoel Alaka
 
Medtech.Capabilities.Frost & Sullivan.2009
Medtech.Capabilities.Frost & Sullivan.2009Medtech.Capabilities.Frost & Sullivan.2009
Medtech.Capabilities.Frost & Sullivan.2009Siddharth Singh
 
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...Merry D'souza
 
Sutherland and International Institute for Analytics HIStalk Webinar - Charti...
Sutherland and International Institute for Analytics HIStalk Webinar - Charti...Sutherland and International Institute for Analytics HIStalk Webinar - Charti...
Sutherland and International Institute for Analytics HIStalk Webinar - Charti...Sutherland Healthcare
 
Our Specialisms - Europe
Our Specialisms - EuropeOur Specialisms - Europe
Our Specialisms - EuropeSummerColes
 
Our Specialisms - USA
Our Specialisms - USAOur Specialisms - USA
Our Specialisms - USASummerColes
 
ESI International - Healthcare
ESI International - HealthcareESI International - Healthcare
ESI International - HealthcareBeckie Palmer
 
The most recommended pharma & life sciences solution providers in 2021
The most recommended pharma & life sciences solution providers in 2021The most recommended pharma & life sciences solution providers in 2021
The most recommended pharma & life sciences solution providers in 2021The Business Fame Magazine
 
ParadigmIT - Medidata Rave Services
ParadigmIT - Medidata Rave ServicesParadigmIT - Medidata Rave Services
ParadigmIT - Medidata Rave ServicesYasser Mohammad
 
Bespoke Strengths Overview
Bespoke Strengths OverviewBespoke Strengths Overview
Bespoke Strengths OverviewCoreData
 
Scimetrika Capability Presentation 0603
Scimetrika Capability Presentation   0603Scimetrika Capability Presentation   0603
Scimetrika Capability Presentation 0603Jean Orelien
 
RAQAM's Company Profile 2023 - Regulatory Affairs Management
RAQAM's Company Profile 2023 - Regulatory Affairs ManagementRAQAM's Company Profile 2023 - Regulatory Affairs Management
RAQAM's Company Profile 2023 - Regulatory Affairs ManagementRaqam Consultancy
 

Semelhante a 2012 2013 Corporate Capabilities (20)

2010 Empiri Stat Corporate Capabilities
2010 Empiri Stat Corporate Capabilities2010 Empiri Stat Corporate Capabilities
2010 Empiri Stat Corporate Capabilities
 
2011 EmpiriStat Corporate Capabilities
2011 EmpiriStat Corporate Capabilities2011 EmpiriStat Corporate Capabilities
2011 EmpiriStat Corporate Capabilities
 
Creativ-Ceutical Corporate Brochure
Creativ-Ceutical  Corporate BrochureCreativ-Ceutical  Corporate Brochure
Creativ-Ceutical Corporate Brochure
 
Readying Your Science for the Real World
Readying Your Science for the Real WorldReadying Your Science for the Real World
Readying Your Science for the Real World
 
Medtech.Capabilities.Frost & Sullivan.2009
Medtech.Capabilities.Frost & Sullivan.2009Medtech.Capabilities.Frost & Sullivan.2009
Medtech.Capabilities.Frost & Sullivan.2009
 
Primary Market Research
Primary Market Research Primary Market Research
Primary Market Research
 
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...
 
Sutherland and International Institute for Analytics HIStalk Webinar - Charti...
Sutherland and International Institute for Analytics HIStalk Webinar - Charti...Sutherland and International Institute for Analytics HIStalk Webinar - Charti...
Sutherland and International Institute for Analytics HIStalk Webinar - Charti...
 
Our Specialisms - Europe
Our Specialisms - EuropeOur Specialisms - Europe
Our Specialisms - Europe
 
Our Specialisms - USA
Our Specialisms - USAOur Specialisms - USA
Our Specialisms - USA
 
ESI International - Healthcare
ESI International - HealthcareESI International - Healthcare
ESI International - Healthcare
 
USG Science
USG ScienceUSG Science
USG Science
 
Cortellis for CTI sell sheet
Cortellis for CTI sell sheetCortellis for CTI sell sheet
Cortellis for CTI sell sheet
 
The most recommended pharma & life sciences solution providers in 2021
The most recommended pharma & life sciences solution providers in 2021The most recommended pharma & life sciences solution providers in 2021
The most recommended pharma & life sciences solution providers in 2021
 
SA_Brochure_2014
SA_Brochure_2014SA_Brochure_2014
SA_Brochure_2014
 
ParadigmIT - Medidata Rave Services
ParadigmIT - Medidata Rave ServicesParadigmIT - Medidata Rave Services
ParadigmIT - Medidata Rave Services
 
Axtria analytics coe datasheet
Axtria analytics coe datasheetAxtria analytics coe datasheet
Axtria analytics coe datasheet
 
Bespoke Strengths Overview
Bespoke Strengths OverviewBespoke Strengths Overview
Bespoke Strengths Overview
 
Scimetrika Capability Presentation 0603
Scimetrika Capability Presentation   0603Scimetrika Capability Presentation   0603
Scimetrika Capability Presentation 0603
 
RAQAM's Company Profile 2023 - Regulatory Affairs Management
RAQAM's Company Profile 2023 - Regulatory Affairs ManagementRAQAM's Company Profile 2023 - Regulatory Affairs Management
RAQAM's Company Profile 2023 - Regulatory Affairs Management
 

2012 2013 Corporate Capabilities

  • 1. Corporate Capabilities Brief 2012-2013 Your Success is Our Success! EmpiriStat, Inc., 13694 Sam Hill Drive, Mount Airy, MD 21771  1-866-935-STAT or 240-744-0000  Fax 866-276-STAT  www.empiristat.com 
  • 2. EmpiriStat, Inc. 2012-2013 Corporate Capabilities Brief Corporate Summary At EmpiriStat our work lies at the intersection of science and practice, in collaboration with partners for the design, implementation and analysis of clinical trials and research studies. With our in-depth biostatistical and methodological experience, we navigate through the myriad of regulations and research guidelines to ensure a successful clinical trial and clinical program, and even more importantly, relationship with the US and European regulatory bodies that may be involved in that pathway. We operate as members of the team, while moving our client’s product forward on its given timeline. EmpiriStat provides research support for animal model studies, in-vivo and in-vitro diagnostic testing and full Phase I to IV clinical support, with post marketing analysis throughout a wide range of therapeutic areas and devices. We offer a variety of customizable services of high-end development and knowledge in: Biostatistics and Statistical Programming Risk Based Monitoring Regulatory planning, support & submission Epidemiological Cohort and Longitudinal for INDs, BLAs, PMA, 510ks, and IDEs Studies Data and Safety Monitoring Board services Capacity Building Training for Existing and (masked and unmasked statistical support), Developing Programs Charter Services and Administrative Duties Clinical Research Support Staffing for Clinical Data Management support Government and Industry EmpiriStat’s founder Dr. Nicole C. Close wasn’t satisfied to cruise the easy road, she has continually challenged herself and those around her. Under the guidance of mentors she was encouraged to think beyond boundaries. This no-limits approach became a unique part of her professional methodology. In March of 2008 with a unique goal in mind: to discover the truth as far as possible, EmpiriStat was born. It has always been EmpiriStat’s position to provide comprehensive and cost efficient clinical development options while delivering the highest quality product. Responsibility to each other and to our clients is our expectation. With established key relationships in Biotechnology, Industry, Government, and Academic clients, EmpiriStat has developed an unparalleled ability to provide comprehensive services. This, in combination Quick Facts with a powerful team of subject matter experts in scientific, regulatory, and logistical aspects of clinical Woman-Owned Small Business research, EmpiriStat has the ability to understand our CAGE Code: 53F97 client's goals and provide the necessary contributions required to achieve them. Driven by our passion for DUNS Number: 826391034 science and overcoming the challenges associated with Small Business NAICS 518210, research, we can confidently state that our clients’ 541519, 541611, 541690, 541712, success is our success. We genuinely care about our collaborators. We get to 541720, 541990, 611420, 611430 know them, their families, their hobbies and we share FWA 00015488 with them as well. It’s the personal attributes of our Navy FWA Addendum team that makes us easy to work with and our passion and excitement for science and research is evident in all Air Force FWA Addendum we do. 2|P age
  • 3. EmpiriStat, Inc. 2012-2013 Corporate Capabilities Brief Why EmpiriStat Strategic U.S. Clinical Development Partner Statistically and Methodologically Focused for Design, Implementation and Analysis Expert Therapeutic, Industry, and Regulatory Knowledge Proven And Successful Track Record Close Proximity To The FDA and Working Knowledge of FDA Divisions and BIMO Personalized "Hands-On" Customer Focus Seamless, Secure Virtual Approach Outstanding Communication Flexible and Responsive Competitive Cost Structure / Tailored Services Dedicated Team for the Program/Client Simply Put… We are Energetic, Love our Careers and are FUN to Work With Recognized by the business community: o Voted the Best Place to Work in Frederick, Maryland (Small Business) in 2011 o Voted 2012 Frederick County Technology Awards, Small Business of the Year o Voted 2011 Entrepreneur of the Year for Women in Technology, Dr. Nicole C. Close, Washington, DC 3|P age
  • 4. EmpiriStat, Inc. 2012-2013 Corporate Capabilities Brief Biostatistical Synergy© It takes a team approach for the successful completion of a research study or for the development of a new device or drug product. It entails substantial integration of collaborators, both internal and external, to research, develop, register, and ultimately market a new product. In order to achieve success one must be able to effectively orchestrate these complex tasks. EmpiriStat has collaborated with clients and organizations in almost every industry and specialty—both in the U.S. and countries around the world. We have developed and refined a rigorous, effective foundation of methodologies that are fluid yet repeatable—enabling us to quickly adapt to each new project and provide the high level of personal service and reliability that is the core of our reputation. EmpiriStat's Methodologies Adapt to Every Industry and Therapeutic More and more pharmaceutical and biotech companies are strategically outsourcing their development needs to CRO partners that have exceptional skills in defined areas. As a result, the role of the CRO as a service provider is rapidly changing. Companies are now moving toward a strategic outsourcing model to maximize clinical development efficiencies and product quality. And as industry diversifies, EmpiriStat is able to adapt and promote our strong capabilities within specific areas and stages of drug development, rather than simply providing time and material support as the traditional CRO does. We have successfully and seamlessly integrated into our collaborators development programs, not only by providing operational support and services, but by providing strategic insight into the unique clinical development challenges. EmpiriStat, Inc. is ideally positioned to provide the most value to our collaborators. Most importantly, we have positioned ourselves with the latest technology and methodology to harness cost effective strategies for start-up and small to mid-size partners. We offer an impressive solution tailored to each client to maximize quality, efficiency, and support, without sacrificing responsiveness or flexibility. Whether it's for a clinical trial, important post-marketing efforts, outcome registry, or augmenting your staff, we bring a strong scientific and integrated approach that positions your research strategy appropriately. By utilizing our collective knowledge and experience, we ensure our collaborators achieve great success. 4|P age
  • 5. EmpiriStat, Inc. 2012-2013 Corporate Capabilities Brief Our Collaborators EmpiriStat has collaborated with more than 30 clients in support of over 100 clinical trials since our beginning in 2008. Our experience encompasses a full range of clinical trial management services from early protocol development through post market surveillance. Our team has supported every stage of drug and device development from bench to bedside. We are always looking to expand our knowledge and apply our skill set to new areas as well. Snapshot of our Industry, Government and Academic Partners 5|P age
  • 6. EmpiriStat, Inc. 2012-2013 Corporate Capabilities Brief Our Experience Government EmpiriStat works closely with government entities such as the United States Department of Defense (DoD), the National Institutes of Health, and the United States Food and Drug Administration for such tasks including:  Clinical Data Management  Biostatistics and Statistical Programming  Safety Monitoring and Reporting  Project Management  Regulatory Processes and Management of Investigational New Drug Applications (INDs)  Safety Monitoring and GCP Training  Providing Subject Matter Expertise in the development of Risk Based Monitoring Tools Non-Profit Organizations EmpiriStat works with non-profit organizations like the United Network for Organ Sharing (UNOS), The Henry M. Jackson Foundation for the Advancement of Military Medicine and the United States President's Emergency Plan for AIDS Relief (PEPFAR) performing such tasks as:  Design of domestic and international epidemiological studies  Health Survey and Questionnaire Design and implementation strategies  Process and management approach for effective data collection and statistical practices  Final statistical analyses for study reports and manuscripts  Scientific mentoring of scientists and validation procedures  Clinical Trial Training of clinicians, nurses and research staff in East and West Africa Private Industry EmpiriStat provides a wide range of services to private companies like Alexza Pharmaceuticals, Soluble Systems, and Research & Diagnostic Antibodies including:  Consulting for integration of statistical analyses in FDA New Drug Applications (NDAs)  Grant writing and funding support  510(k) and PMA support  In-vitro device trial support  Validation of final statistical results for an Integrated Summary of Safety (ISS) and Integrated Summary of Efficacy (ISE)  Providing management strategy and design methodology for clinical and health research  Design, management, and clinical monitoring of clinical studies Academia and Private Practice EmpiriStat collaborates with academic institutions like the Schulze Diabetes Institute at the University of Minnesota and Coastal Carolinas Integrated Medicine on tasks including  Regulatory strategy for studies leading to a Biologics License Application (BLA) with the FDA  Clinical data management, project management, biostatistics and clinical monitoring  Clinical trial support and statistical analysis for IND studies  Grant writing support and strategy 6|P age
  • 7. EmpiriStat, Inc. 2012-2013 Corporate Capabilities Brief Summary of Services EmpiriStat is committed to providing the highest quality services, superior performance, and unmatched customer accommodation. Every team member at EmpiriStat possesses a comprehensive knowledge of regulatory affairs and applicable FDA and ICH guidances-- from our statistical and programming group, to clinical data management to our clinical monitors. It is our internal strengths, corporate structure and standard operating procedures, and most importantly synergy as a team, that eliminates errors and redundancies that are not tolerable. Below we provide a brief overview of our expertise, but highly recommend calling us to speak with us personally. Biostatistics and Statistical Programming Our biostatistician’s provide statistical guidance on all clinical development program strategies, development of optimal study designs, endpoint selection, sample size, randomization, blinding, and the appropriate statistical methods for each design. They provide guidance on the selection of optimal efficacy and safety endpoints and are particularly versed in various statistical methods, including what may or may not be accepted for products and devices with the FDA. They know the importance of planning for the collection of data, in terms of the study design and testing of the hypothesis(es). Sample size and power calculations are devised based on previous literature, FDA expectations and guidelines, and the appropriate statistical methodology chosen. We understand and are ready to recommend the appropriate statistical techniques, even when those techniques may not be the “standard” for the field currently or devise a mathematical approach to address that specific situation. We can cite the traditional tests that we have experience in but our knowledge and the application of that knowledge is where we excel. We have served as presenting statisticians at the DSMB on behalf of the study and Sponsor, as well as the DSMB statistician, and as the unblinded reporting statistician. We prepare all appropriate statistical programming and reports based on our function, have a full understanding of the data, and can provide quick analyses and reporting during the meeting if the Chair requires it. Any statistician that works in any role of the DSMB is thoroughly versed in sequential monitoring techniques, understands the role of the DSMB, is able to explain the statistical methodology of those sequential techniques, futility analyses, statistical penalties for multiple looks at the data, and statistical justification for stopping early for efficacy or safety. In addition, we provide full CDISC implementation for your submissions through SDTM conversion and ADaM datasets. We have internally implemented documented techniques that saves our collaborators time during SDTM conversion, and have tips at the beginning of the studies on how some of our methods can be adapted early in the process. It is never too early to have your ISS and ISE analyses and plans developed to be implemented through your various phases as well. It is our excellence in communication of statistical methodology, reasoning and presentation of analyses, that has captured the interest of our clients. Our explanation to an investigator, interdisciplinary team, Data and Safety Monitoring Board, or a lay person is made in a way for that concept to be understood. We all consider ourselves at EmpiriStat constant learners, educators and mentors. If we cannot explain to you why we should do something the way we propose, or give you options and the reasoning behind those options, and you do not understand—that is our fault. It is our duty to teach, recommend and learn. 7|P age
  • 8. EmpiriStat, Inc. 2012-2013 Corporate Capabilities Brief Training An effective training plan is an essential requirement at the start of a study to deliver consistency throughout the study by ensuring a uniform interpretation of the study protocol, CRFs, safety, and all study procedures. Our training agenda’s include study-specific training (protocol review and execution, CRF training, safety) as well as general clinical training (ICH/GCP, investigative site expectations, and other key topics). With EmpiriStat you get a team that is well versed and experienced in preparing and delivering training for clinical researchers. We also provide Capacity Building for research centers within and outside the United States. The EmpiriStat Series 101 Training is comprised of a four day hands- on course that provides participants the background and essentials of Epidemiology, Clinical Data Management, Clinical Trial Foundations, and Statistics for Non-Statisticians. Participants are able to receive a valuable education and the tools necessary to design a clinical trial, generate data reports and provide scientific critique of research. The course also teaches attendees how to develop work-plans and standard operating procedures to ensure the safety of study subjects during a clinical trial. Building from that solid knowledge base, we offer a Series 201 standard course as well. In this course, the building blocks of Series 101 are emphasized, but are expanded upon in Epidemiological Investigations and Analyses, Advanced Topics in Clinical Trials, Data Management Strategies and Implications and Statistical Analyses and Interpretation. Training methods are very important, and as such we used didactic, hands on and small group sessions using skills in these areas. Our approach is through the use of slides and presentations, group case studies, group discussion and exploration, directed question and answer periods and summary quizzes for the main topics of the day. Our success in providing this training is evident in that we have been a leading training provider to the President’s We go anywhere in the world for you! Emergency Program for Aids Research (PEPFAR) and have delivered countless training sessions in clinical research throughout Africa. There are a number of clinical trial models that may be utilized within an organization and its departments, between an organization and its subcontractors, and within a Clinical Research Network. Regardless of the model employed, for clinical trials to be successful, there must be collaboration amongst the stakeholders. There should be an examination of each group’s functional roles, an understanding of the technical methods utilized as well as an appreciation of the behaviors, relationships and values that enable an organization to carry out complex tasks. 8|P age
  • 9. EmpiriStat, Inc. 2012-2013 Corporate Capabilities Brief Our Training Style We understand that in the real world, personnel usually learn by seeing a problem, raising a question then finding the answer. Our courses are structured in such a way that the material is taught in a purposeful, sequential way, modeling after real world problem solving. Trainees will gain by the end of the course a solid improvement/understanding, as a result of the learning activities, through the use of:  the use of slides and presentations  small group case study sessions on the topic area  individual work on a problem for resolution  group discussions and exploration  directed question and answer periods  summary quizzes of the main topics for the day We also offer tailored training for our clients whether you want an on-site brown-bag training session or an off-site training event at a designated site. Our training series and educational training modules include Biostatistics, Data Management and Standards, Pharmacovigilence and Safety Reporting, Clinical Monitoring and Data and Safety Monitoring Board Training. Clinical Research Support Staffing At EmpiriStat our staffing division focuses on providing clinical research professionals and expertise for all therapeutic areas for products and devices. We serve the clinical research needs of our clients with whom we partner. Our approach allows us to provide a wide range of tactical and experienced professionals with strategic solutions to the primary challenges that our clients face. Our approach is to listen, consult and partner with our clients. We understand the criticality of selecting the right candidate for the right job, so we select each one carefully. The first step in our recruiting process is identification of the appropriate skills sets, educational and training background, and experience level required to perform each job. For each new requirement, we consider the job duties and requirements, educational and training background needed, experience level required, and any special skills necessary. Only through understanding our clients’ needs and careful screening of candidates can we select the right person for each job. We consider factors such as the desired salary range, the difficulty of finding the skills set, and the skills that are required versus the skills that are helpful to have. Our staff carefully screens candidates’ qualifications as they relate to each client through intense question and inquiry. This careful selection process leads to an increased level of client satisfaction and project success. 9|P age
  • 10. EmpiriStat, Inc. 2012-2013 Corporate Capabilities Brief Risk Based Monitoring Tools Risk based prioritization monitoring has changed the way we look at study management, monitoring and statistical reporting. The first of two new draft guidance for industry, "Oversight of Clinical Investigations— Risk-Based Approach to Monitoring" was released in August 2011. In conjunction with this new guidance, the FDA will be describing a new review mechanism for monitoring Sponsors and Clinical Research Organizations (CROs) during the IND application phase. At EmpiriStat we understand and know how to implement the FDA guidances and at the same time develop the steps to save a Sponsor time and resources during their clinical development program. A risk based monitoring program provides the necessary risk assessment for clinical conduct and data collection that applies available monitoring resources according to the identified risks – and reassesses those risks on a regular basis throughout the study. Monitoring resources include Statistical Prioritization Reporting as well as Regulatory Monitoring. Sponsor Preventative Maintenance Program (SPMP) Our Sponsor Preventative and Maintenance Program (SPMP), is a program in which we develop and implement standard site metrics at the beginning of the IND phase for your clinical development program, in preparation for NDA filing. We create Sponsor and site level Statistical Monitoring Reports with their subsequent risk rankings to identify any clinical and logistical issues that will trigger possible GCP question or concern, thus resulting in a higher probability of FDA inspection during your NDA process. When applicable, our team works with the Sponsor to go out to the site to remedy and train on identified issues. EmpiriStat’s SPMP is an ongoing process; the metrics built will remain and will be automatically initiated for all new studies and reports created for the Sponsor on a weekly, biweekly or monthly basis for review. All reports are posted electronically to a Sponsor on a dedicated and secured file sharing system, which the Sponsor controls on who receives access. Site Reports may also be sent and reviewed by our team with your sites. We give comments and updates as needed on all reports. 10 | P a g e
  • 11. EmpiriStat, Inc. 2012-2013 Corporate Capabilities Brief Case Studies Challenge: A pharmaceutical company was only months away from filing their NA with the FDA. They did not have an in-house Biostatistics/Statistical Programming group for review and writing of the ISS SAP and to conduct validation programming for their program. Solution: EmpiriStat collaborated with the company and provided all of the services required as the Sponsor’s in-house Biostatistics and Statistical Programming group to support both the ISS and the NDA filing within a very condensed timeframe without compromising quality. Result: The Company received biostatistical guidance, writing, reviewing and statistical validation programming from EmpiriStat to complete the filing within the existing company timelines. The company saved time and money by consulting with EmpiriStat who provided flexible, time efficient and cost effective services in an expedited manner set by the client’s needs. Challenge: The client had contracted with EmpiriStat for part-time Senior Clinical and Regulatory Affairs Management and expertise. The client was also in the process of contracting for a full service CRO to provide Data Management, Clinical Monitoring, Safety Reporting, Biostatistics, and Regulatory support for their multi-center clinical trial. However, the client was having contracting difficulties and the trial timelines were being delayed. Solution: EmpiriStat was contracted by client to expand their current services to provide a Bridge until the CRO could be selected and contracted. In a condensed timeline of just 4 months, EmpiriStat created the deliverables and provided the on-site professionals to initiate the clinical trial (including complete Case Report Forms, Manual of Procedures, a Safety Reporting System, Study Specific Procedures for a Data and Safety Monitoring Board, all training modules, Clinical Monitoring Plan and 2 certified research coordinators and one professional consultant). A clear transition plan was developed between EmpiriStat’s bridge of services to the CRO. Result: The client moved forward with the deliverables required to initiate the trial without further delay, had no cost or delay associated with a new group getting up to speed on the trial since EmpiriStat was currently providing management guidance, and saved time and money when the CRO was hired since all primary deliverables had been created for the study. Challenge: A European device company was preparing for filing with the U.S. FDA with a device already approved in Europe. They had consulted with an academic Biostatistician in the U.S., but were unsure of the analyses and recommendations that the Biostatistician had made and was looking for an independent opinion. Solution: EmpiriStat was consulted to review the statistical analyses and recommendations and to provide their own assessment prior to the company filing. EmpiriStat Principal Biostatistician, Dr. Nicole C. Close, who has extensive U.S. Regulatory experience, along with an EmpiriStat Statistician located in the United Kingdom who is well versed in EMEA guidance, reviewed the information and provided a detailed Statistical Risk Analysis for the filing. Result: The device company was provided with a detailed Statistical Risk Analysis summary and an independent assessment. The company made modifications to their filing based on EmpiriStat’s recommendations and successfully filed with the U.S. FDA. 11 | P a g e
  • 12. EmpiriStat, Inc. 2012-2013 Corporate Capabilities Brief Our Commitment We at EmpiriStat are committed to building long lasting collaborative relationships with our clients. We believe that to forge these effective relationships, we must remain true to our key values: responsibility, integrity, value, and commitment to excellence in every task we undertake. We bring the required knowledge and experience to your research and development, along with accurate documentation, rigorous quality control, and regulatory compliance. We will work efficiently under your tight project deadlines without compromising quality. Our goal is to ensure the highest statistical validity through every project phase… as well as the ability to effectively communicate the results to a variety of audiences. EmpiriStat’s highly qualified staff includes Biostatisticians, Programmers, Regulatory Specialists, Project Managers, Clinical Research Coordinators and Administrators, Quality Assurance Document Specialists, and Data Managers, all led by our founder, Dr. Nicole Close, who is an experienced and trained Biostatistician and Clinical Trialist. Dr. Close is trained in Epidemiology and Biostatistics and has more than 16 years of professional experience conduction and managing clinical trials and epidemiological research, including the management of coordinating centers, and large-scale, multi-site data collection and statistical analysis activities. Her passion for her field is expressed in the diligence and insightfulness she brings to each project and therapeutic area. Dr. Close’s diverse background provides a solid foundation for EmpiriStat’s corporate knowledge, supplemented by a team of highly trained colleagues in complementing areas of expertise. Our staff continuously seeks opportunities to interact with and educate professionals from many disciplines, both in biostatistics and in methodological improvements that improve the outcomes and enhance the knowledge gained from research. VALUE BENEFITS Experienced team successful in providing and Understanding of needs and requirements ensures managing clinical research support that deliverables are managed on time, and within budget Flexibility EmpiriStat fits our resources to our collaborator’s needs. This flexibility allows us to provide solutions for any clinical research project Understanding Clinical Trials In-depth understanding of the challenges faced when managing and supporting clinical trials 12 | P a g e
  • 13. EmpiriStat, Inc. 2012-2013 Corporate Capabilities Brief Testimonials I would do anything for EmpiriStat. You can trust them to do what We asked Dr. Close to jump into a very specific role on a team already they say they will do, which isn’t always true about contractors. They moving at high speed toward an NDA. She did this quickly, ably and have a sense of urgency and their work is top-notch. The fact they are cheerfully, and her work was integral to the submission. Her attention to a virtual company never entered my mind because they always detail and process were particularly appreciated, and her collaborative deliver—and in this economy, that is what it most important. manner perfectly set the stage for a productive alliance. Roger House, President Robert S. Fishman, MD, FCCP Axiom Corporation VP, Clinical Development Alexza Pharmaceuticals, Inc. EmpiriStat runs a client-focused business with customer satisfaction The EmpiriStat team proved to be my closest collaborators on my research and quality of services as their top priorities. They serve as the grant proposal. They brought a precise knowledge of the grant review protocol statisticians for my research studies, participate in data safety process, study design, and power analysis. They were extremely helpful in monitoring boards, and even developed a statistical capacity-building refining the study design to improve the statistical analysis. EmpiriStat workshop for the new researchers in Africa with whom I work. They brought a genuine excitement about the science of our research and were have a totally positive attitude—and are efficient, effective, very easy to reach. They asked insightful questions and were very prompt responsive, and flexible. in their analysis and responses. It was a great pleasure to work with such professionals." Dr. Judi Chamberlin U.S. Military HIV Research Program Theodore Henderson, MD, PhD Kisumu, Kenya The Synaptic Space I’d heard EmpiriStat would be a good company to handle our You have a great programming team that is highly efficient and statistical analysis. They were very patient while we waited for communicates with ease. They do not sweat when the heat is on. They regulatory clearance, then incredibly fast and efficient when clearance were able to run with little direction and produce high quality outputs; a finally came. Their data cleaning was nothing short of amazing, and nice group of “thinkers” not just “doers”. I am looking forward to when I asked them on short notice to write some abstracts for reviewing the datasets next week or this weekend. Our sponsor will be conferences, I was blown away by how quickly this was done—and excited/pleased to have the tight timeline delivered ahead of schedule. they were extremely well-written. I can’t say anything bad about Great work!” EmpiriStat. Raven Quinn, MS Mark Breda Biostatistician Makerere University School of Medicine Sarah Cannon Research Institute Kampala, Uganda You’re on the A list, but we haven’t finalized the clinical studies One of the great characteristics Dr. Close brought to our projects was her budget for 2010. You may safely assume we’ll call you when we great investment in ensuring the integrity of our data. Her respect for both ramp up. Your supervision and back-up on the mechanics of our our data and our study goals was a primary factor in our success. Dr. Close programming and data management was incredibly helpful in ’09. was remarkably thorough in the processes she brought to managing data as well as in the analytic programming she created for us. Robert S. Fishman, MD, FCCP VP, Clinical Development Dr. Bob O’Brien Alexza Pharmaceuticals, Inc. The CDM Group, Inc. The auditors were really nice and easy to work with and made the Good job on getting all of the reports turned around so quickly. I am sure process very painless! UAB is very, very happy. Sandra M. Berney, RN, ASN, CCTC Amy Putnam St. Vincent Indianapolis Hospital Survey Services Manager UNOS Department of Evaluation and Quality Thank you so much for all of EmpiriStat’s knowledge and effort. I I wanted to thank you again for the great support of Cerescan…they were consider myself lucky to be working with you! VERY impressed (and so was I!...) Mike Webber M. Veatch Soluble Systems Quintiles 13 | P a g e
  • 14. EmpiriStat, Inc. 2012-2013 Corporate Capabilities Brief Contact Us Nicole C. Close, PhD President and Principal Biostatistician 13694 Sam Hill Drive Mount Airy, Maryland USA 21771 (TF) 866-935-7828 (x 703) (T) 240-744-0000 (x703) (F) 866-276-7828 nclose@empiristat.com Caylee A. Ortega Chief Operating Officer/Director of Business Development 13694 Sam Hill Drive Mount Airy, Maryland USA 21771 (TF) 866-935-7828 (x 702) (T) 240-744-0000 (x702) (F) 866-276-7828 cortega@empiristat.com 14 | P a g e